SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,406,000 | -74.6% | 5,000,000 | -77.3% | 0.04% | -71.4% |
| Q2 2021 | $29,153,000 | -59.1% | 22,058,000 | -59.6% | 0.15% | -70.8% |
| Q1 2021 | $71,344,000 | +67.3% | 54,558,000 | +212.9% | 0.53% | +65.5% |
| Q4 2020 | $42,643,000 | -37.0% | 17,437,000 | -46.7% | 0.32% | -60.9% |
| Q3 2020 | $67,675,000 | -4.7% | 32,702,000 | +5.9% | 0.82% | -29.0% |
| Q2 2020 | $71,021,000 | -51.3% | 30,877,000 | -67.6% | 1.15% | -55.6% |
| Q1 2020 | $145,892,000 | -26.2% | 95,377,000 | -6.0% | 2.59% | +10.8% |
| Q4 2019 | $197,618,000 | +68.8% | 101,515,000 | +14.7% | 2.34% | +47.6% |
| Q3 2019 | $117,060,000 | -37.2% | 88,515,000 | +5.7% | 1.58% | -44.3% |
| Q2 2019 | $186,503,000 | +40.3% | 83,765,000 | +13.8% | 2.84% | -6.5% |
| Q1 2019 | $132,955,000 | – | 73,615,000 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |